G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2024 17:50 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
May 01, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
May 01, 2024 06:25 ET
|
G1 Therapeutics
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
April 17, 2024 09:00 ET
|
G1 Therapeutics
G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 04, 2024 10:30 ET
|
G1 Therapeutics
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024 16:20 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 01, 2024 16:20 ET
|
G1 Therapeutics
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
February 28, 2024 06:30 ET
|
G1 Therapeutics
G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
February 27, 2024 08:30 ET
|
G1 Therapeutics
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
February 15, 2024 08:30 ET
|
G1 Therapeutics
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024